Click Therapeutics develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As part of our research, we conduct studies to evaluate these mobile applications in the treatment of disease.
Clinical trials are carefully designed research studies that evaluate safety, efficacy and effectiveness of new treatments or interventions. The process involves screening for eligibility, providing informed consent, actively participating in the study, and undergoing monitoring under the care of experienced healthcare professionals.
Our mission to provide patients everywhere access to safe and effective prescription digital therapeutics is made possible by patient participation in our clinical trials.
Reasons to Participate
A study to evaluate two digital apps as potential treatments for individuals age 18 years or older with schizophrenia symptoms, such as motivation or their ability to enjoy life
Active, not recruiting
A continuation study to evaluate a second course of a digital app for the treatment of experiential negative symptoms of schizophrenia, such as motivation or their ability to enjoy life
Active, not recruiting
A study to evaluate a digital app for the prevention of episodic migraine in individuals who are 18 years or older receiving CGRP therapy
Completed
A study to evaluate a digital app for the prevention of episodic migraine in individuals who are 18 years or older
Completed
A study to evaluate the effects of a digital intervention on attentional biases and cognition in multiple sclerosis, breast cancer, and lung cancer
Completed
A study to evaluate the effects of a digital app on disrupting scratching in atopic dermatitis and psoriasis
Completed
A study to evaluate the potential treatment effect of a digital app in individuals diagnosed with schizophrenia who are age 18 years or older
Completed
A study to evaluate how individuals with negative symptoms of schizophrenia interact with a digital app
Completed
A study to evaluate how individuals with negative symptoms of schizophrenia interact with a digital app
Completed
A study to evaluate the feasibility of the digital app as treatment for individuals with schizophrenia
Completed
A study to evaluate the overall effects of treatment with a digital app in individuals with schizophrenia who are age 18 years or older
Completed